學大教育(000526.SZ):相關展期協議書項下剩餘借款本金金額11.15億元
格隆匯6月7日丨學大教育(000526.SZ)公佈,經公司第九屆董事會第二十四次會議、2021年第二次臨時股東大會審議通過,公司與西藏紫光卓遠股權投資有限公司(“紫光卓遠”)、芯鑫商業保理(深圳)有限責任公司、芯鑫商業保理(天津)有限責任公司(上述兩公司以下合稱“芯鑫保理”)簽署了《展期協議書》,按照《展期協議書》的相關約定,公司已使用非公開發行股票的募集資金及自有資金向紫光卓遠償還2.4675億元借款,使用自有資金向芯鑫保理償還2.5億元借款。
截至公吿披露日,公司非公開發行股票用於“償還股東紫光卓遠借款”項目的募集資金已使用完畢,《展期協議書》項下剩餘借款本金金額11.15億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.